| Value | ₹6.05 Cr |
|---|
BSE filing, NSE: VAGHANI. Summary written from the filing by ALFA Finder's alert engine.
Emrock Corporation Ltd: key numbers
- Share price
- ₹214.20
- Market cap
- ₹338.9 Cr
- Revenue (annual)
- ₹2.06 Cr
- Net profit (annual)
- ₹1.21 Cr
- P/E (TTM)
- 275.7×Sector 27.1×
- Promoter holding
- 74.63%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emrock Corporation Ltd
All →Emrock Corporation Convertible Warrants
Emrock Corporation converted 55,00,000 warrants into equal equity shares after receiving Rs 4.54 Crore balance subscription. Paid-up capital rises to Rs 21.32 Crore.
- Value
- ₹4.54 Cr
Emrock Corporation Board Meeting Date
Emrock Corp scheduled a board meeting on 04 Nov 2026 to approve Q2 results and a new MOA object. No financial figures or decisions are yet in place.
Emrock Corporation Bags New Order from Uttar Gujarat Vij Company Limited
Emrock Corporation received confirmation of PPAs with UGVCL for 12 MW of solar power over 25 years. Total confirmed UGVCL commitments now stand at 40 MW.
- From
- Uttar Gujarat Vij Company Limited (UGVCL)
- Execution
- 25 years PPA tenure; generation expected by March 20, 2028 (one project) and March 23, 2028 (two projects)
- solar capacity
- 12.0 MW
Emrock Corporation Annual General Meeting
Emrock Corporation clarified a typo in its EGM notice, correcting 'infrequently traded' to 'frequently traded' for its shares. No financial impact results from this correction.
Emrock Corporation Other Announcement
Emrock Corporation Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b), detailing promoter and public shareholding distribution as of September 30, 2026.
Emrock Corporation Management Change
Emrock Corporation Limited has appointed Mrs. Rekha Sejpal as its Secretarial Auditor, effective April 1, 2026.
Other preferential issue announcements
All →Aptus Pharma Preferential Issue
Aptus Pharma got BSE in-principle approval for a preferential issue of 15,99,270 shares at a minimum Rs. 280 each. The issue is worth about Rs. 44.78 Crore.
- Value
- ₹44.78 Cr
Taurian Mps Preferential Issue
Taurian MPS allotted 2,31,200 equity shares and 8,48,800 convertible warrants at Rs 419 each on preferential basis. Upfront consideration totals Rs 18.58 Crore, with warrant balances payable on conversion.
- Value
- ₹18.58 Cr
Bizotic Commercial Preferential Issue
Bizotic Commercial corrected its EGM notice, revising the Rs 146.41 Crore preferential warrant issue. Members may re-vote on that item until 2 November 2026.
- Value
- ₹146.4 Cr
Kross Preferential Issue
Kross allotted 15 lakh preferential shares at Rs 212 to non-promoters, plus 15 lakh convertible warrants to promoters. Combined value totals Rs 63.60 Crore.
- Value
- ₹63.60 Cr
- Execution
- Warrants convertible into equity shares within 18 months from the date of allotment
Dhariwalcorp Preferential Issue
Dhariwalcorp's EGM approved the issue of 33,00,000 equity shares to the promoter on preferential basis. The proposed 1,70,01,000 convertible warrants were not approved.
Milkfood Preferential Issue
Milkfood Ltd allotted 1,100,000 shares each to Director Sudhir Avasthi and Deepankar Barat in a preferential issue. Total consideration was ₹6.60 Crore.
- Value
- ₹6.60 Cr